2 weeks ago
28
ARTICLE AD BOX
Researchers from Mass General Brigham and Dana-Farber Cancer Institute report that a single dose of an oncolytic virus, a genetically engineered virus designed to infect and kill cancer cells, can draw immune cells deep into brain tumors and keep them active there. Their findings, published in Cell, explain how this approach improved survival in patients with glioblastoma, the most aggressive and common form of primary brain cancer, during a recent clinical trial.
Related
This 5-day diet helped Crohn’s patients feel better fast
14 hours ago
12
English (US) ·